These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 7939751)

  • 1. Global advances in prostate cancer diagnosis and therapy.
    Walia G; Sun Y; Soule HR
    Asian J Androl; 2013 May; 15(3):299-300. PubMed ID: 23603920
    [No Abstract]   [Full Text] [Related]  

  • 2. Capromab pendetide. A review of its use as an imaging agent in prostate cancer.
    Lamb HM; Faulds D
    Drugs Aging; 1998 Apr; 12(4):293-304. PubMed ID: 9571393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic value of single-photon emission computed tomography/computed tomography fusion to radioimmunoscintigraphic imaging of prostate cancer.
    Sodee DB; Sodee AE; Bakale G
    Semin Nucl Med; 2007 Jan; 37(1):17-28. PubMed ID: 17161036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting tomoregulin for radioimmunotherapy of prostate cancer.
    Zhao XY; Schneider D; Biroc SL; Parry R; Alicke B; Toy P; Xuan JA; Sakamoto C; Wada K; Schulze M; Müller-Tiemann B; Parry G; Dinter H
    Cancer Res; 2005 Apr; 65(7):2846-53. PubMed ID: 15805286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of monoclonal antibodies for imaging and therapy of prostate cancer.
    Bander NH
    Semin Oncol; 1994 Oct; 21(5):607-12. PubMed ID: 7939751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunotherapy of prostate cancer.
    Smith-Jones PM
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):297-304. PubMed ID: 15640793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of radiolabeled monoclonal antibodies in prostate cancer.
    David KA; Milowsky MI; Kostakoglu L; Vallabhajosula S; Goldsmith SJ; Nanus DM; Bander NH
    Clin Genitourin Cancer; 2006 Mar; 4(4):249-56. PubMed ID: 16729907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted alpha-therapy for control of micrometastatic prostate cancer.
    Li Y; Russell PJ; Allen BJ
    Expert Rev Anticancer Ther; 2004 Jun; 4(3):459-68. PubMed ID: 15161444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunotherapy of prostate cancer].
    Schulze H; Sommerfeld HJ
    Urologe A; 1993 Sep; 32(5):382-9. PubMed ID: 8212423
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.